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Abstract 
Osteoarthritis (OA) is characterized by degen-
erative changes within joints that involved quan-
titative and/or qualitative alterations of cartilage
and synovial fluid lubricin, a mucinous glycopro-
tein secreted by synovial fibroblasts and chondro-
cytes. Modern therapeutic methods, including tis-
sue-engineering techniques, have been used to
treat mechanical damage of the articular cartilage
but to date there is no specific and effective treat-
ment. This study aimed at investigating lubricin
immunohistochemical  expression  in  cartilage
explant from normal and OA patients and in car-
tilage constructions formed by Poly (ethylene gly-
col) (PEG) based hydrogels (PEG-DA) encapsulat-
ed  OA  chondrocytes.  The  expression  levels  of
lubricin were studied by immunohistochemistry:
i) in tissue explanted from OA and normal human
cartilage;  ii)  in  chondrocytes  encapsulated  in
hydrogel PEGDA from OA and normal human car-
tilage. Moreover, immunocytochemical and west-
ern blot analysis were performed in monolayer
cells from OA and normal cartilage. The results
showed an increased expression of lubricin in
explanted tissue and in monolayer cells from nor-
mal  cartilage,  and  a  decreased  expression  of
lubricin in OA cartilage. The chondrocytes from
OA cartilage after 5 weeks of culture in hydrogels
(PEGDA)  showed  an  increased  expression  of
lubricin compared with the control cartilage. The
present study demonstrated that OA chondrocytes
encapsulated in PEGDA, grown in the scaffold and
were able to restore lubricin biosynthesis. Thus
our  results  suggest  the  possibility  of  applying
autologous  cell  transplantation  in  conjunction
with  scaffold  materials  for  repairing  cartilage
lesions in patients with OA to reduce at least the
progression of the disease.
Introduction
Articular cartilage homeostasis is the result
of an intricate interplay between anabolic and
catabolic,  anti-  and  pro-inflammatory,  anti-
and pro-apoptotic mediators. These processes
act  also  as  protective  mechanisms  whether
there is a sub lethal injury characterized by an
increased survival of chondrocytes, which play,
in that way, a central role in the growth of the
new  cartilage  and  extracellular  matrix.1,2 As
chondrocytes represent versatile regulators for
this cartilage equilibrium, they are highly sen-
sitive and responsive to mechanical, biochem-
ical and other stressful stimuli.3 However, any
kind  of  cartilage  injury  can  lead  to  an  irre-
versible  cartilage  loss,  since  differentiated
chondrocytes do not divide and hence do not
compensate for these defects. Additionally, car-
tilage homeostasis is disturbed by the predom-
inance of directly and indirectly catabolic act-
ing  factors  such  as  pro-inflammatory
cytokines, which can result in cartilage dam-
age and secondary osteoarthritis (OA).4
Osteoarthritis, also known as degenerative
arthritis, is a multifactorial degenerative joint
disease,  characterized  by  degenerative
changes within joints that involved quantita-
tive and/or qualitative alterations of cartilage
and synovial fluid lubricin, a mucinous glyco-
protein  secreted  by  synovial  fibroblasts  and
chondrocytes. It can be classified into either
primary or secondary depending on whether
there is o an identifiable underlying cause or
not. The progressive erosion of articular carti-
lage, leading to joint space narrowing, subchon-
dral sclerosis, subchondral cyst, synovial inflam-
mation,  and  marginal  osteophyte  formation,
characterizes the disease process of OA.5-7 It is
known that OA is the result of mechanical and
biological  processes  that  modify  cartilage
homeostasis.8,9
Modern therapeutic methods, including tis-
sue-engineering techniques, have been used
to  treat  the  mechanical  damage  of  articular
cartilage. Among a number of these recently
developed  methods,  the  autologous  chondro-
cyte transplantation (ACT) seems promising.
In this procedure, the chondrocytes were iso-
lated from a cartilage, these chondrocytes are
cultured in vitro, and subsequently, they can be
transplanted  into  the  damaged  area.  Some
studies have revealed that these cells are capa-
ble  of  producing,  in  vivo,  an  extracellular
matrix  of  chemical  composition  and  biome-
chanical properties similar to those of normal
hyaline cartilage.10-12 In this respect, chondro-
cytes of the middle and deep zones synthesize
aggrecan at high rates, and thereby contribute
to the ability of cartilage to bear compressive
loads; on the other hand, the chondrocytes of
the superficial zone exhibit a number of spe-
cific  functions  including  the  synthesis  and
secretion  of  superficial  zone  protein  (SZP)
also  known  as  proteoglycan  4  (Prg4)  or
lubricin.
Lubricin (227.5-kDa) is a mucinous glyco-
protein  secreted  by  synovial  fibroblasts  and
chondrocytes.13 This molecule is partly respon-
sible for the lubrication of apposed and pres-
surized cartilage, surfaces enabling low fric-
tion  levels.14-16 Lubricin  provides  essential
chondroprotective properties to articular carti-
lage as shown by the lack of cartilage surface
integrity  and  surface  disruption  in  lubricin
knockout  mice.17 Furthermore,  quantitative
and/or qualitative alterations of cartilage and
synovial fluid lubricin have been described in
OA. Lubricin has been localized on the surface
of  multiple  synovial  tissues,  including  carti-
lage,  meniscus,  ligament,  and  tendon,18-24
whereupon it acts as a boundary lubricant and
as a deterrent against abnormal protein depo-
sition  and/or  cellular  adhesion.  In  addition,
lubricin  contributes  to  the  load  dissipating
elasticity of synovial fluid. Thus, the expres-
sion of lubricin in chondrocytes delivered on
absorbable  scaffolds  seems  to  be  absolutely
neccessary. As regards this, some studies have
demonstrated  that  chondrocytes  from  the
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superficial zone of bovine cartilage, used in
explants,  monolayer,  transplant  and  alginate
constructions are able to express lubricin.25,26
However, to the knowledge of authors, no
investigation  has  ever  dealt  with  lubricin
expression in human autologus chondrocytes
derived  from  normal  and  OA  cartilage  and
encapsulated  into  scaffold.  Accordingly,  this
study aimed at investigating lubricin immuno-
histochemical,  immunocytochemical  expres-
sion  and  western  blot  analysis  in  cartilage
explant from normal and OA patients and in
cartilage construction formed by Poly (ethyl-
ene glycol) (PEG) based hydrogels (PEG-DA)
encapsulated OA chondrocytes. 
Materials and Methods 
Subjects
Osteoarthritic cartilage was obtained from
25  patients,  15  males  and  10  females,  with
similar  height  and  weight,  who  underwent
knee joint replacement at the Orthopaedic and
Traumatology  Unit,  Hospital  of  Suzzara,
Mantova, Italy, under an approved Institutional
Review  Board  protocol  after  obtaining  the
required informed consent from the patients.
Surgery  was  performed  because  of  the  pain
and the functional impairment. The median of
the age of the OA patients was 56 (range 34-78
years). Tissue samples were graded according
to the histopathological Mankin scores27 and
included only pieces of moderate-to-severe OA
(Mankin score 6-14). The patients were not
smokers,  occasionally  taking  NSAIDs  (nons-
teroidal anti-inflammatory drugs) in addition
to the classical treatment for knee OA com-
posed of hot packs, therapeutic ultrasound and
terminal isometric exercises. The females did
not take estrogen replacement therapy (ERT)
that may influences the physiological home-
ostasis of the joint. 
The  diagnosis  was  based  on  clinical  and
radiological criteria, included physical exami-
nation, X-ray imaging and MRI of the injured
knee.  According  to  Ahlbäck  classification
(grade  IV,  moderate  bone  attrition)  and
Kellgren  &  Lawrence  classification  patients
had an OA of the knee of grade 3 or 4 with mod-
erate diminution of joint space or joint space
greatly impaired with sclerosis of subchondral
bone.28 Samples  used  as  the  control  were
obtained from 16 patients with similar height
and weight to patients with OA knee, 8 males
and 8 females, without history of primary or
secondary arthritis, from the same Hospital,
under an approved Institutional Review Board
protocol  and  after  the  informed  consent
obtained from the patients. The median of the
age  of  these  patients  was  40  (range  35-59
years). Knee joint were removed because of
traumatic events. Macroscopic and microscop-
ic examination of the knee showed no signs of
degenerative or inflammatory joint disease. 
Isolation of chondrocytes and 
culture conditions
To  isolate  the  chondrocytes  from  OA  and
non OA articular cartilage, they were incubat-
ed  in  Dulbeco’s  modified  eagle’s  medium
(DMEM, GIBCO, Grand Island, NY, USA) con-
taining  0.2%  collagenase  (Worthington
Biochemical Corporation, Lakewood, NJ, USA)
and 5% FBS (fetal bovine serum, GIBCO) for
14-16 h at 37°C and 5% CO2. The resulting cell
suspension was then filtered through 70 ʼm
nylon  filters  (Cell  Strainer;  Falcon,  Franklin
Lakes, NJ, USA) and washed three times with
phosphate  buffered  saline  (PBS)  containing
100  U/ml  penicillin  and  100  ʼg/mL  strepto-
mycin. The number and size destribution of
the isolated cells were then determined with a
Z2  Coulter  Counter  and  Size  Analyzer
(Beckman Coulter, Inc., Palo Alto, CA, USA).
After isolation, the chondrocytes were plated
onto separate 10 cm tissue culture dishes at a
density of 10,000 cells/cm2. Cells were incubat-
ed at 37°C and 5% CO2 in chondrocyte medium
composed  of  DMEM  containing  10%  fetal
bovine serum, 0.4 mM proline, 50 ʼg/mL ascor-
bic acid, 10 mM HEPES, 0.1 mM non-essential
amino acid, and 100 U/mL penicillin and 100
ʼg/mL  streptomycin.  Culture  medium  was
changed twice weekly. The cells were observed
with  an  Axioplan  Zeiss  light  microscope
(Germany)  and  photographed  with  a  digital
camera (Canon, Japan).
Cell encapsulation in hydrogels
(PEGDA)
Cells  were  encapsulated  in  PEGDA  hydro-
gels for 3, 4 and 5 weeks. Briefly, chondrocytes
(passage 3 or 4) were suspended in 10% (w/v)
PEGDA (SunBio, Orinda, CA, USA) solution in
sterile PBS with 100 U/mL penicillin and 100
µg/mL streptomycin (Gibco). The photoinitia-
tor Irgacure 2959 (Ciba Specialty Chemicals,
Tarrytown, NY, USA) was used at 0.05% (w/v)
final concentration. The photo initiation and
encapsulation processes have been previously
determined to be biocompatible. Chondrocytes
were resuspended in 95 µL of polymer solution
at a concentration of 20ﾥ106 cells per milliliter.
The cell-polymer solution was added to a cylin-
drical  silicone-tubing  mold  with  an  internal
diameter of 4.75 mm and a construct height of
5 mm. The tubing was attached to the glass
microscope  slide  using  silicon  lubricant.
Prepolymer  (macromer)  was  exposed  to  UV
light  (365  nm)  for  5  min  to  induce  gelling.
Constructions were removed from the molds
and  cultured  at  37°C,  5%  carbon  dioxide  in
chondrocyte medium. The culture medium was
changed twice weekly. The scaffolds were pho-
tographed with a digital camera (Canon, Tokio,
Japan).
Fixation, dehydration and embed-
ding of hydrogels
The hydrogel was fixed by incubating it in
500 ʼL of 4% paraformaldehyde (w/v) in PBS
(Invitrogen),  pH  7.4  overnight  (~12  h).
Several  steps  involving  temperature  and  pH
changes were necessary to dissolve this chem-
ical  (to  dissolve  the  paraformaldehyde,  heat
the solution to 55°C while stirring. Once dis-
solved, 1N NaOH drop by drop was added to the
solution until it became clear. Dilute HCl was
use to lower the pH to 7.4). Then the hydrogel
was dehydrated using the following sequence:
70% EtOH x 1 h, 80% EtOH x 1.5 h, 95% EtOH
x 12 h, 100% EtOH x 1.5 h-repeat twice, Xylene
x 1 h.
The hydrogel was placed in a metal mold
(and embed in paraffin at 60°C overnight (~12
h). The paraffin was poured out and replaced
with  fresh  paraffin.  An  embedding  cassette
(Fisher) was placed on top of the mold and
additional paraffin was added to fill the cas-
sette. Cooled for 1 h using the cold surface of
the embedding station (the embedding system
used was Leica EG1150). Sections of 4-5 ʼm
thick  were  cut  from  paraffin  blocks  using  a
microtome and they were mounted on saline-
coated slides and stored at room temperature.
Immunohistochemistry
For  immunohistochemical  analysis,  sec-
tions  were  incubated  for  30  min  in  0.3%
H2O2/methanol to quench endogenous peroxi-
dase activity then rinsed for 20 min with phos-
phate-buffered  saline  (PBS;  Bio-Optica,
Milano, Italy). The sections were irradiated (5
min x 3) in capped polypropylene slide-holders
with citrate buffer (pH 6), using a microwave
oven  (750  W)  to  unmask  antigenic  sites.
Then, the sections were incubated with diluted
rabbit  polyclonal  anti-lubricin  antibody
(abcam, Cambridge Science Park, Cambridge,
CB4 0FL, UK), (diluted 1:50 in PBS) overnight
at  4°C.  The  secondary  antibody,  biotinylated
mouse/anti-rabbit IgG was applied (for 30 min
at  RT),  followed  by  the  avidin-biotin-peroxi-
dase complex (Vector Elite Kit Abbott, Chicago,
IL, USA) for 30 min, at room temperature. The
immunoreaction was visualized by incubating
the  sections  for  4  min  in  a  0.1%  3,3'-
diaminobenzidine and 0.02% hydrogen perox-
ide  solution  (DAB  substrate  kit,  Vector
Laboratories,  CA,  USA).  The  sections  were
lightly  counterstained  with  Mayer’s  haema-
toxylin  (Histolab  Products  AB,  Goteborg,
Sweden)  mounted  in  GVA  mount  (Zymed,
Laboratories  Inc.,  San  Francisco,  CA,  USA)
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observed with an Axioplan Zeiss light micro-
scope (Germany) and photographed with a dig-
ital camera (Canon, Japan). 
Immunocytochemistry
Immunostaining for lubricin was performed
on control and OA cell cultures in cells after
fourth passages in monolayer cultured. Briefly,
cells were fixed with 4% phosphate-buffered
paraformaldehyde, for 20 min at room temper-
ature; quenching was performed with a solu-
tion of 2% hydrogen peroxide (H2O2) and 10%
methanol in phosphate-buffer saline (PBS) for
1 min. To permeabilize the cells, fresh 0.3%
Triton X-100 solutions in PBS was used for 5
min.  The  cells  were  then  treated  with  5%
bovine serum albumin (BSA) in PBS for 1 hour
at room temperature. BSA is a blocking agent
used  to  prevent  non-specific  binding  of  the
antibody. After blocking, the cells were incu-
bated  overnight  with  a  primary  Rabbit  anti-
PRG4 unconjugated (1:200 dilution, Millipore,
Billerica,  MA,  USA)  antibody.  A  fluoresceine
isothiocyanate (FITC) labeled anti-rabbit anti-
body  (1:100,  Santa  Cruz  Biotechnology,  Inc.,
Santa Cruz, CA, USA) was used as a secondary
antibody. Cover slips containing the cells were
washed and mounted in PBS/glycerol (50:50)
and placed on glass microscope slides. In all
instances  negative  controls  without  primary
antibody  were  performed.  Cover  slips  were
analyzed using a Nikon Eclipse TE200 fluores-
cence  microscope  and  photographed  with  a
digital camera (Canon) and positive cells were
counted over the entire cover slips.
Evaluation of immunohistochem-
istry and immunocytochemistry
The lubricin-staining status was identified
as either negative or positive. Immunohisto  -
chemistry positive staining was defined as the
presence of a brown detection chromogen on
the edge of the hematoxylin-stained cell nucle-
us, distributed within the cytoplasm or in the
immediate lacunar/pericellular space evaluat-
ed  by  the  light  microscope.  Immunocyto  -
chemistry positive staining was defined as the
presence of fluorescence detection on the edge
of the black background, distributed within the
cytoplasm or in the immediate lacunar/pericel-
lular  space  evaluated  by  the  fluorescence
microscope.
Stain  intensity  and  the  proportion  of
immunopositive  cells  were  assessed  also  by
light and fluorescence microscopy. Intensity of
staining  (IS)  was  graded  on  a  scale  of  0-4,
according to the following assessment: 0, no
detectable staining; 1, weak staining; 2, mod-
erate  staining;  3,  strong  staining;  4,  very
strong staining. The percentage of Lubricin-1
immunopositive cells (Extent Score=ES) was
independently evaluated by 3 investigators (2
anatomical morphologists and one histologist)
and scored as a percentage of the final number
of 100 cells in five categories: 0, <5%; +, 5-
30%; ++, 31-50%; +++, 51-75%, and ++++,
>75%. Counting was performed at x200 magni-
fication.
Positive  and  negative  controls  were  per-
formed to test the specific reaction of primary
antibodies used in this study at a protein level.
For positive control testing the sections and
cells  culture  from  synovium  underwent  an
immunoperoxidase  process.  The  positive
immunolabeling for lubricin was cytoplasmic.
For negative control testing sections and cells
of cartilage were treated with normal rabbit
serum instead of the specific antibodies.
Western blot analysis
The expression of lubricin was evaluated by
Western blot analysis. The monolayer chondro-
cytes were washed twice with ice-cold PBS and
collected with lysing buffer (10 mM Tris-HCl
plus 10 mM KCl, 2 mM MgCl2, 0.6 mM PMSF,
and 1% SDS, pH 7.4). After cooling for 30 min
at 0º C, cells were sonicated. Twenty micro-
grams of total protein, present in the super-
natant, were loaded on each lane and separat-
ed by 4-12% Novex Bis-Tris gel electrophoresis
(NuPAGE, Invitrogen, S.Giuliano Milanese, MI,
Italy). Proteins were then transferred to nitro-
cellulose membranes (Invitrogen) in a wet sys-
tem. The transfer of proteins was verified by
staining  the  nitrocellulose  membranes  with
Ponceau  S  and  the  Novex  Bis-Tris  gel  with
Brillant blue R. Membranes were blocked in
Tris buffered saline containing 0.01% Tween-
20  (TBST)  and  5%  non-fat  dry  milk  at  4°C
overnight. Rabbit polyclonal lubricin (abcam,
Cambridge Science Park, Cambridge, CB4 0FL,
UK),  280  KDa  (1:500  dilition),  and  mouse
monoclonal anti-a-tubulin antibodies (Sigma,
Milano, Italy), 50 KDa (1:5000) were diluted in
TBST and membranes incubated for 24 h at
room  temperature.  Antibodies  were  detected
with  horseradish  peroxidase-conjugated  sec-
ondary antibody using the enhanced chemilu-
minescence detection Supersignal West Pico
Chemiluminescent  Substrate  (Pierce  Che  -
mical  Co.,  Rockford,  IL,  USA).  Bands  were
measured densitometrically and their relative
density calculated based on the density of the
a-tubulin bands in each sample. Values were
expressed  as  arbitrary  densitometric  units
(A.D.U.) corresponding to signal intensity.
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Figure 1. A) Lubricin immunohistochemistry (cytoplasmic and perinuclear immunola-
beling) specimen from control cartilage (tissue explanted); strong lubricin immunolabel-
ing of chondrocytes; magnification x20; scale bar: 100 µm. B) Magnification of panel A,
black arrow; magnification x40; scale bar: 50 µm. C) magnification of panel A, red arrow;
magnification x40; scale bar: 50 µm. D) Lubricin immunohistochemistry specimen from
OA cartilage (tissue explanted); weak lubricin immunolabeling of chondrocytes; magni-
fication x20; scale bar: 100 µm. E) No immunoreaction was observed in the negative con-
trol treated with PBS without the primary antibodies (tissue explanted); magnification
x20; scale bar: 100 µm. F) Percentage of lubricin positive cells out of the total number of
cells counted in control cartilage and in OA cartilage.[European Journal of Histochemistry 2011; 55:e31] [page 165]
Statistical analysis
All  variables  were  normally  distributed.
Comparisons between two means were tested
with the Student’s t-test; comparisons between
different means were tested with ANOVA test.
P-values of less than 0.01 were considered sta-
tistically significant. Ten fields from randomly
selected slides were observed under fluores-
cence and a light microscope. Each field was
photographed with a digital camera. On each
photomicrograph  three  observers,  blinded  to
the type of sample, identified and counted the
number of total cells as well as the number of
these cells exhibiting a positive reaction. The
proportion of positive cells was calculated for
each photomicrograph and a mean value was
obtained  for  each  sample.  The  results  were
expressed as a percentage. All data were ana-
lyzed with the SPSS program (SPSS® release
16.0, Chicago, IL, USA). 
Cohen’s kappa was applied to measure the
agreement between the three observers and
averaged  over  all  three  to  evaluate  overall
agreement using the following grading: 0-0.2
(slight), 0.21-0.40 (fair), 0.41-0.60 (moderate),




Lubricin immunohistochemical staining in
explanted tissue was appreciated in an overall
extracellular matrix (ECM) of cells of both nor-
mal and OA specimens. Articular cartilage dis-
played a layer of lubricin on the surface of tis-
sues. However different patterns of immuno  -
positive cells in the two sets of specimens were
appreciated. Expression of lubricin was inves-
tigated  via  immunohistochemistry,  in  vivo
explanted tissue. A very strong lubricin stain-
ing (IS, 4; ES, ++++) was observed in control
cartilage where almost all chondrocytes were
immunolabeled (Figure 1A,B,C). On the other
hand a weak lubricin immunoreaction (IS, 1;
ES, +) was appreciated in OA cartilage where
few cells were immunostained (Figure 1D). No
immunoreaction was observed in the negative
control treated with PBS without the primary
antibodies (Figure 1E). Both ES and IS were
significantly greater (P<0.01) in control carti-
lage compared to OA cartilage. Interobserver
agreement, measured using the Kappa coeffi-
cient, was 0.94 (almost perfect).
In PEGDA hydrogel light microscopy obser-
vation showed different patterns of immuno  -
positive  cells  in  the  two  sets  of  specimens.
Expression  of  lubricin  was  investigated  via
immunohistochemistry,  in  control  chondro-
cytes and in OA chondrocytes encapsulated in
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Figure 2. A) Lubricin immunohistochemistry (cytoplasmic and perinuclear immunola-
beling) specimen from control chondrocytes after 3 weeks of encapsulations in PEGDA
hydrogels. Strong lubricin immunolabeling in chondrocytes; magnification x20; scale
bar: 100 µm. B) Lubricin immunostained specimen from control chondrocytes after 4
weeks of encapsulation in PEGDA hydrogels. Strong lubricin immunolabeling in chon-
drocytes; magnification x20; scale bar: 100 µm. C) Lubricin immunostained specimen
from control chondrocytes after 5 weeks of encapsulations in PEGDA hydrogels; very
strong lubricin immunolabeling in chondrocytes; magnification x20; scale bars: 100 µm.
D) No immunoreaction was observed in the negative control treated with PBS without
the primary antibodies; magnification x20; scale bars: 100 µm. 
Figure 3. A) Lubricin immunohistochemistry specimen from OA chondrocytes after 3
weeks of encapsulations in PEGDA hydrogels; weak lubricin immunolabeling in chondro-
cytes; magnification x20; scale bars: 100 µm. B) Magnification (x40) of the panel A; scale
bar: 50 µm. C) Lubricin immunostained specimen from OA chondrocytes after 4 weeks of
encapsulation in PEGDA hydrogels; strong lubricin immunolabeling in the chondrocytes;
magnification x20; scale bars: 100 µm. D) Lubricin immunostained specimen from OA
chondrocytes after 5 weeks of encapsulation in PEGDA hydrogels; very strong lubricin
immunolabeling in the chondrocytes; magnification x20; scale bar: 100 µm. [page 166] [European Journal of Histochemistry 2011; 55:e31]
PEGDA hydrogel at 3, 4 and 5 weeks of culture.
A strong (IS, 3; ES, +++) lubricin immunore-
action was shown in control chondrocytes after
3  weeks  of  culture  and  many  chondrocytes
were  immunolabeled  (Figure  2A).  After  4
weeks  of  culture  the  immunoreactions  was
strong (IS, 3; ES, +++) (Figure 2B) and after 5
weeks of culture was very strong (Figure 2C)
(IS, 4; ES, ++++) were almost all the chondro-
cytes were immunolabeled by lubricin suggest-
ing an increased expression. No immunoreac-
tion was observed in the negative control (IS,
0; ES, 0) (Figure 2D). A weak/moderate (IS, 1;
ES, ++) lubricin immunoreaction was seen in
OA  chondrocytes  encapsulated  in  PEGDA
hydrogels  after  the  3rd  week  of  culture  and
nearly half chondrocytes were immunostained
(Figure 3A, B). After 4 weeks of culture strong
(IS, 3; ES, +++) lubricin immunoreaction was
demonstrated in OA chondrocytes encapsulat-
ed in PEGDA hydrogels (Figure 3C) and after 5
weeks  of  culture  was  very  strong  compared
with control chondrocytes (IS, 4; ES, ++++)
(Figure  3D).  IS  and  ES  were  significantly
greater (P<0.01) in control chondrocytes com-
pared with OA chondrocytes, at the 3rd, 4th and
5th weeks (Figure 4). Interobserver agreement,
measured  using  the  Kappa  coefficient,  was
0.91 (almost perfect).
Immunocytochemistry
Fluorescence  microscopy  observation
showed a detection of lubricin in cells from
control cartilage and in OA cartilage after the 4
passages using immunocytochemistry. Strong
(IS,  4;  ES,  ++++)  lubricin  immunoreaction
was observed in control cartilage (Figure 5A).
The chondrocytes from OA cartilage exhibited
a weak (IS, 1; ES, +) lubricin immunoreaction,
with only few cells fluorescing (Figure 5B). No
immunoreaction was observed in the negative
control treated with 1% BSA without the pri-
mary antibodies (Figure 5C). ES was signifi-
cantly  greater  (P<0.01)  in  control  chondro-
cytes  compared  to  OA  chondrocytes  (Figure
5D).  Inter  observer  agreement,  measured
using the Kappa coefficient, was 0.91 (almost
perfect).
Western blot
In this study, we also examined, by Western
blot,  the  production  of  lubricin  in  human
monolayer chondrocytes from normal and OA
cartilage. On the 24th day we have investigated
the effects of different cultures on the release
of  lubricin.  Negligible  amounts  of  lubricin
were  produced  by  monolayer  chondrocytes
from OA cartilage. In contrast, lubricin potent-
ly was induced by chondrocytes from normal
cartilage (Figure 6).
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Figure 4. Percentage of lubricin positive cells out of the total number of cells counted in
control chondrocytes and in OA chondrocytes after 3, 4 and 5 weeks in PEGDA hydro-
gels.
Figure 5. A) Lubricin immunocytochemistry (cytoplasmic and perinuclear immunolabel-
ing) specimen from control chondrocytes; strong lubricin immunolabeling in cells at
fourth passage of culture; magnification x20; scale bars: 100 µm. B) Lubricin immunocy-
tochemistry (cytoplasmic and perinuclear immunolabeling) specimen from OA chondro-
cytes; weak lubricin immunolabeling in cells at fourth passage of culture; magnification
x20; scale bar: 50 µm. C) No immunoreaction was observed in the negative control treat-
ed with PBS without the primary antibodies; magnification x20; scale bar: 100 µm. D)
Percentage of lubricin positive cells out of the total number of cells counted in control
chondrocytes and in OA chondrocytes. 
Figure  6.  Lubricin  expression
induced  in  human  monolayer
chondrocytes from normal car-
tilage  and  human  monolayer
chondrocytes  from  OA  carti-
lage  determined  by  Western
blot  analysis.  Data  show  the
relative  expression  (mean  ±
SEM) of lubricin calculated as
arbitrary  densitometric  units
(A.D.U.)  collected  from  three
independent  experiments.
*P<0.01 compared to monolay-
er chondrocytes.[European Journal of Histochemistry 2011; 55:e31] [page 167]
Discussion
New therapeutic strategies for OA cartilage
deterioration are a novel biomedical challenge.
As  we  know,  tissue  engineering  focuses  on
restoration, maintenance, or improvement of
tissue  function  through  the  development  of
biological  substitutes.  The  principle  obstacle
for clinical transplantation today is the short-
age of donor organs. For this reason, tissue
engineering and regenerative medicine have
become  promising  and  important  fields  of
research that may offer new sources of tissues
and organs for transplantation. Poly (ethylene
glycol) (PEG) based hydrogels have attracted
wide interest as a scaffolding material for tis-
sue  engineering  applications.29-32 Hydrogels
encompass  a  class  of  scaffolds  with  many
attractive  features  for  cartilage  tissue  engi-
neering.29-32 Hydrogels are made from water-
soluble polymer chains that are cross-linked to
form water-insoluble gel networks. Cells in the
polymer solution can be encapsulated into the
hydrogel during the cross-linking process. The
resulting gel network can be designed to have
a high water content, enabling efficient trans-
port of nutrient and waste products to and from
cells. Polymer cross-linking and hydrogel for-
mation  can  be  achieved  by  various  physical
and chemical mechanisms.33 This scaffold, like
some  others,  is  thus  designed  to  perform  a
number of biological functions including stim-
ulation of cells to synthesize ECM, proliferate,
migrate, prevent apoptosis, and/or differenti-
ate.  The  characterization  of  extracellular
matrix anabolic factors and proteins produced
by cells in the scaffolds is critical to evaluate
the success of a tissue engineering system.
In  this  study  we  have  evaluated  lubricin
expression in chondrocytes from articular car-
tilage of the knee, from patients with OA and
compared them to normal cartilage chondro-
cytes, both in vivo, on paraffin sections, this
evaluation was also carried out after chondro-
cytes  encapsulation  in  hydrogel  PEGDA,  in
vitro after isolation of these chondrocytes and
through western blot analysis. 
Lubricin  is  a  chondroprotective  glycopro-
tein, which acts as a vital counteragent against
aberrant  protein  and/or  cellular  adhesion,
infiltration and over-proliferation, and serves
as a critical boundary lubricant between oppos-
ing  cartilage  surfaces.  This  protein  is  less
expressed with aging and during OA, moreover
the lubricin gene is differently expressed in
the synovium of RA and OA implying a possible
role in the pathogenesis of these diseases.34
Furthermore, impaired lubricin expression is
associated  with  the  onset  of  early  OA  in  a
sheep meniscectomy model.35
Here, for the first time, we have shown that
lubricin  is  down  regulated  in  OA  cartilage
explants  and  cell  cultures  from  knee  joints.
This result is in line with previous studies that
advocate intraarticular supplementation with
lubricin for OA joints.36,37 More interestingly,
we demonstrated in our study that OA chon-
drocytes  encapsulated  in  PEGDA  scaffolding
are able to restore lubricin biosynthesis. In fact
after 4 weeks of culture of OA chondrocytes
encapsulated  in  PEGDA  hydrogel,  lubricin
expression nearly reached the level of the con-
trol  scaffold.  This  increased  expression  of
lubricin in OA chondrocytes may, somehow, be
related  to  the  absence  of  cytokines,  which
seem to influence lubricin biosynthesis. A dis-
regulation of lubricin metabolism, under the
influence of elevated cytokine concentrations
in  diseased  or  damaged  joints,  has  been
described,14,38-40 and this, in time, might there-
by lead to lubrication deficiencies and loss of
function. In this respect, it has been claimed
that a decrease in synovial fluid lubricin con-
centrations  following  anterior  cruciate  liga-
ment injury may place the joint at an increased
risk  of  wear-induced  damage,  as  a  conse-
quence of lack of boundary lubrication, poten-
tially leading to secondary osteoarthritis. 
In this study, we clearly demonstrated that
OA chondrocytes grown in PEGDA hydrogels
were able to express lubricin. This investiga-
tion shows an increased expression of lubricin
in  chondrocytes  encapsulated  in  hydrogel
PEGDA scaffolding from OA patients after 3, 4
and 5 weeks of culture. In particular, chondro-
cytes from OA cartilage after 5 weeks of culture
in  hydrogels  (PEGDA)  showed  an  increased
expression of lubricin comparable to the con-
trol cartilage. These are preliminary data, and
further studies using a longer incubation time
will be useful to better understand the poten-
tial effect of PEGDA. In conclusion our study
suggests the possibility of applying autologous
cell transplantation (ACT) in conjunction with
scaffolding  materials  for  repairing  cartilage
lesions in patients with OA in order to reduce,
at least, the progression of the disease. 
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